These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 15357668)

  • 1. NMR solution structure of a potent cyclic nonapeptide inhibitor of ICAM-1-mediated leukocyte adhesion produced by homologous amino acid substitution.
    Sillerud LO; Burks EJ; Brown WM; Brown DC; Larson RS
    J Pept Res; 2004 Oct; 64(4):127-40. PubMed ID: 15357668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR-derived model of interconverting conformations of an ICAM-1 inhibitory cyclic nonapeptide.
    Sillerud LO; Burks EJ; Wester MJ; Brown DC; Vijayan S; Larson RS
    J Pept Res; 2003 Sep; 62(3):97-116. PubMed ID: 12895272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and ICAM-1-docking properties of a cyclic peptide from the I-domain of LFA-1: an inhibitor of ICAM-1/LFA- 1-mediated T-cell adhesion.
    Xu CR; Yusuf-Makagiansar H; Hu Y; Jois SD; Siahaan TJ
    J Biomol Struct Dyn; 2002 Apr; 19(5):789-99. PubMed ID: 11922836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel cyclic peptide inhibits intercellular adhesion molecule-1-mediated cell aggregation.
    Shannon JP; Silva MV; Brown DC; Larson RS
    J Pept Res; 2001 Aug; 58(2):140-50. PubMed ID: 11532073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of binding properties of ICAM-1 peptides to LFA-1: inhibitors of T-cell adhesion.
    Anderson ME; Tejo BA; Yakovleva T; Siahaan TJ
    Chem Biol Drug Des; 2006 Jul; 68(1):20-8. PubMed ID: 16923022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peptide derived from LFA-1 protein that modulates T-cell adhesion binds to soluble ICAM-1 protein.
    Jois SD; Teruna TJ
    J Biomol Struct Dyn; 2003 Apr; 20(5):635-44. PubMed ID: 12643766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence recognition of alpha-LFA-1-derived peptides by ICAM-1 cell receptors: inhibitors of T-cell adhesion.
    Yusuf-Makagiansar H; Yakovleva TV; Tejo BA; Jones K; Hu Y; Verkhivker GM; Audus KL; Siahaan TJ
    Chem Biol Drug Des; 2007 Sep; 70(3):237-46. PubMed ID: 17718718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR solution structure of the inserted domain of human leukocyte function associated antigen-1.
    Legge GB; Kriwacki RW; Chung J; Hommel U; Ramage P; Case DA; Dyson HJ; Wright PE
    J Mol Biol; 2000 Feb; 295(5):1251-64. PubMed ID: 10653701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model of the alphaLbeta2 integrin I-domain/ICAM-1 DI interface suggests that subtle changes in loop orientation determine ligand specificity.
    Legge GB; Morris GM; Sanner MF; Takada Y; Olson AJ; Grynszpan F
    Proteins; 2002 Aug; 48(2):151-60. PubMed ID: 12112684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain.
    Kallen J; Welzenbach K; Ramage P; Geyl D; Kriwacki R; Legge G; Cottens S; Weitz-Schmidt G; Hommel U
    J Mol Biol; 1999 Sep; 292(1):1-9. PubMed ID: 10493852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the solution conformations of a cell-adhesive peptide LBE and its reverse sequence EBL.
    Jois SD; Hughes R; Siahaan TJ
    J Biomol Struct Dyn; 1999 Dec; 17(3):429-44. PubMed ID: 10636079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-induced structure of the mammalian tachykinin neuropeptide gamma.
    Chandrashekar IR; Dike A; Cowsik SM
    J Struct Biol; 2004 Dec; 148(3):315-25. PubMed ID: 15522780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic control of allosteric antagonism of leukocyte function antigen-1 and intercellular adhesion molecule-1 interaction.
    Nam K; Maiorov V; Feuston B; Kearsley S
    Proteins; 2006 Aug; 64(2):376-84. PubMed ID: 16705652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptide isolated by phage display binds to ICAM-1 and inhibits binding to LFA-1.
    Welply JK; Steininger CN; Caparon M; Michener ML; Howard SC; Pegg LE; Meyer DM; De Ciechi PA; Devine CS; Casperson GF
    Proteins; 1996 Nov; 26(3):262-70. PubMed ID: 8953648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer-NMR and docking studies identify the binding of the peptide derived from activating transcription factor 4 to protein ubiquitin ligase beta-TrCP. Competition STD-NMR with beta-catenin.
    Pons J; Evrard-Todeschi N; Bertho G; Gharbi-Benarous J; Tanchou V; Benarous R; Girault JP
    Biochemistry; 2008 Jan; 47(1):14-29. PubMed ID: 18052253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure of Eucommia antifungal peptide: a novel structural model distinct with a five-disulfide motif.
    Huang RH; Xiang Y; Tu GZ; Zhang Y; Wang DC
    Biochemistry; 2004 May; 43(20):6005-12. PubMed ID: 15147184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The signature molecular descriptor. 3. Inverse-quantitative structure-activity relationship of ICAM-1 inhibitory peptides.
    Churchwell CJ; Rintoul MD; Martin S; Visco DP; Kotu A; Larson RS; Sillerud LO; Brown DC; Faulon JL
    J Mol Graph Model; 2004 Mar; 22(4):263-73. PubMed ID: 15177078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Ca2+ binding cyclic peptide derived from the alpha-subunit of LFA-1: inhibitor of ICAM-1/LFA-1-mediated T-cell adhesion.
    Jois SD; Tibbetts SA; Chan MA; Benedict SH; Siahaan TJ
    J Pept Res; 1999 Jan; 53(1):18-29. PubMed ID: 10195438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structure by NMR of circulin A: a macrocyclic knotted peptide having anti-HIV activity.
    Daly NL; Koltay A; Gustafson KR; Boyd MR; Casas-Finet JR; Craik DJ
    J Mol Biol; 1999 Jan; 285(1):333-45. PubMed ID: 9878410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational analysis of furanoid epsilon-sugar amino acid containing cyclic peptides by NMR spectroscopy, molecular dynamics simulation, and X-ray crystallography: evidence for a novel turn structure.
    van Well RM; Marinelli L; Altona C; Erkelens K; Siegal G; van Raaij M; Llamas-Saiz AL; Kessler H; Novellino E; Lavecchia A; van Boom JH; Overhand M
    J Am Chem Soc; 2003 Sep; 125(36):10822-9. PubMed ID: 12952461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.